Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report) dropped 4.9% during mid-day trading on Friday. The stock traded as low as $3.92 and last traded at $3.92. Approximately 19,967 shares changed hands during mid-day trading, a decline of 47% from the average daily volume of 37,647 shares. The stock had previously closed at $4.12.
Invizyne Technologies Stock Performance
The company’s 50 day moving average price is $5.97 and its 200-day moving average price is $7.44.
About Invizyne Technologies
Invizyne Technologies, Inc is a biotechnology company focused on developing cell-free biomanufacturing technologies. Its platform is designed to use engineered enzymes and biological pathways outside living cells to produce complex molecules more efficiently and sustainably than conventional chemical synthesis or cell-based fermentation.
The company develops solutions for the production of specialty chemicals, pharmaceutical ingredients, and other high-value compounds. Its technology is intended to support the manufacture of molecules that can be difficult or costly to produce using traditional methods, with potential applications across the pharmaceutical, industrial, and consumer-product sectors.
Invizyne Technologies was founded in 2014 and is headquartered in Monrovia, California.
See Also
- Five stocks we like better than Invizyne Technologies
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
